Pharmacotherapy for Stimulant Use Disorders
The Carlat Addiction Treatment Report, Volume 9, Number 3, May 2021
Rehan Aziz, MD.
Associate Professor of Psychiatry and Neurology, Rutgers Robert Wood Johnson Medical School.
Dr. Aziz has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
There are no approved pharmacotherapies for stimulant use disorders. Lots of medications have been studied and the results have been mixed. Here we provide you with the latest data, and some treatment recommendations.